Comprehensive characterization and clinical impact of concomitant genomic alterations in EGFR-mutant NSCLCs treated with EGFR kinase inhibitors
Ying Cheng, Lixia Ma, Ying Liu, Jing Zhu, Ying Xin, Xianhong Liu, Ying Wang, Tingting Zhang, Changliang Yang, Sheng Wang, Hongxia Cui, Liang Zhang, Jixin Dai, Lin Shao, Jing Lin, Junyi Ye, Hao Liu
Topics & Concepts
MedicineConcomitantInternal medicineEpidermal growth factor receptorOncologyBevacizumabLung cancerErlotinibMutantTyrosine-kinase inhibitorProgression-free survivalTyrosine kinaseCancer researchMutationCancerOverall survivalChemotherapyReceptorGeneBiologyGeneticsLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment